Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Discovery and development of oral recombinant protein vaccines, based on its proprietary oral28.7M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States28.7M100.00%